James Heath of the California Institute of Technology in the U.S. will build stable, low-cost protein capture agents to target proteins. If successful, these agents could replace expensive and unstable monoclonal antibodies that are currently needed for diagnostic tests.
Grant ID
OPP1017990
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False